🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the producers of Tylenol, asserting the firms withheld safety concerns that the pain reliever posed to pediatric cognitive development.

The lawsuit arrives a month after Former President Trump advocated an unproven link between consuming acetaminophen - also known as acetaminophen - during pregnancy and autism spectrum disorder in offspring.

Paxton is filing suit against the pharmaceutical giant, which previously sold the drug, the sole analgesic approved for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he stated they "deceived the public by profiting off of suffering and pushing pills ignoring the dangers."

The manufacturer asserts there is lacking scientific proof linking Tylenol to autism.

"These manufacturers lied for decades, knowingly endangering numerous people to increase profits," the attorney general, a Republican, stated.

The manufacturer stated officially that it was "very worried by the perpetuation of misinformation on the security of acetaminophen and the potential impact that could have on the well-being of women and children in America."

On its online platform, Kenvue also stated it had "consistently assessed the applicable studies and there is insufficient valid information that demonstrates a verified association between taking paracetamol and autism."

Associations acting on behalf of doctors and health professionals concur.

ACOG has stated acetaminophen - the key substance in Tylenol - is one of the few options for women during pregnancy to address discomfort and fever, which can pose significant medical dangers if left untreated.

"In multiple decades of research on the consumption of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the use of acetaminophen in any period of pregnancy causes neurological conditions in young ones," the group said.

The lawsuit references current declarations from the Trump administration in asserting the medication is reportedly hazardous.

Last month, Trump caused concern from public health officials when he instructed pregnant women to "struggle intensely" not to use Tylenol when sick.

Federal regulators then released a statement that physicians should contemplate reducing the consumption of Tylenol, while also declaring that "a proven link" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head Kennedy, who oversees the FDA, had pledged in spring to undertake "a massive testing and research effort" that would identify the source of autism in a matter of months.

But experts warned that discovering a sole reason of autism - considered by experts to be the consequence of a complex mix of genetic and external influences - would prove challenging.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that affects how individuals perceive and engage with the surroundings, and is recognized using doctors' observations.

In his court filing, Paxton - a Trump ally who is running for federal office - alleges Kenvue and J&J "intentionally overlooked and tried to quiet the science" around acetaminophen and autism.

This legal action seeks to make the corporations "destroy any commercial messaging" that claims Tylenol is reliable for expectant mothers.

The court case echoes the complaints of a group of mothers and fathers of young ones with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in two years ago.

Judicial authorities dismissed the lawsuit, saying studies from the plaintiffs' authorities was lacking definitive proof.